Discovery of Thiazolidine-2,4-dione Analogues as SGK1 Inhibitors

키워드

참고문헌 (22)

1. Zhu R, "The pros-pect of serum and glucocorticoid-inducible kinase 1(SGK1)in cancer therapy : a rising star", Ther Adv Med Oncol, 12, pp.1758835920940946~ (2020)
2. Isikbay M, "Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer", Horm Cancer, 5, pp.72~89 (2014)
3. Lee LYW, "Serum-and Glucocorticoid-induced Kinase Sgk1Directly Promotes the Differentiation of Colorectal Cancer Cells and Restrains Metastasis", Clin Cancer Res, 25, pp.629~640 (2019)
4. Skor MN, "Glucocorticoid receptor antagonism as a novel therapy for triple-negative breast cancer", Clin Cancer Res, 19, pp.6163~6172 (2013)
5. Abbruzzese C, "The small molecule SI113 synergizes with mito-tic spindle poisons in arresting the growth of human glioblastoma multiforme", Oncotarget, 8, pp.110743~110755 (2017)
6. Conza D, "The SGK1 inhibitor SI113 induces autophagy, apoptosis, and endoplasmic reticulum stress in endometrial cancer cells", J Cell Physiol, 232, pp.3735~3743 (2017)
7. Wu M, "Micro-RNA-144-3p suppresses tumor growth and angiogenesis by tar-geting SGK3 in hepatocellular carcinoma", Oncol Rep, 38, pp.2173~2181 (2017)
8. Wang Y, "SGK3 is an estrogen-inducible kinase promoting estrogen-mediated sur-vival of breast cancer cells", Mol Endocrinol, 25, pp.72~82 (2011)
9. Wang Y, "SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1", Mol Endocrinol, 28, pp.935~948 (2014)
10. Kobayashi T, "Characterization of the structure and regulation of two novel isoforms of serum-and glucocorticoid-induced protein kinase", Biochem J (1999)
11. Zhao B, "Crystal structure of the kinase domain of serum and gluco-corticoid-regulated kinase 1 in complex with AMP PNP", Protein Sci, 16, pp.2761~2769 (2007)
12. Tessier M, "Role of the Phox homology domain and phosphorylation in activation of serum and glucocorticoid-regulated kinase-3", J Biol Chem, 281, pp.23978~23989 (2006)
13. Hammond M, "Design and synthesis of orally bioavailable serum and glucocorticoid-regulated kinase 1(SGK1)inhibitors", Bioorg Med Chem Lett, 19, pp.4441~4445 (2009)
14. -sulfonamides as Highly Active and Selective SGK1 Inhibitors, "ACS Med Chem Lett", 2015, 73~78
15. Ackermann TF, "EMD638683, a novel SGK inhibitor with antihypertensive pot-ency", Cell Physiol Biochem, 28, pp.137~146 (2011)
16. Ortuso F, "In silico identification and biological evaluation of novel selec-tive serum", glucocorticoid-inducible kinase 1 inhibitors based on the pyrazolo-pyrimidine scaffold, 2014, pp.54, 1828~1832
17. Gong GQ, "Identification, structure modification, and characterization of potential small-molecule SGK3 inhibitors with novel scaffolds", Acta Pharmacol Sin, 39, pp.1902~1912 (2018)
18. Dakin LA, "Discovery of novel benzylidene-1, 3-thiazolidine-2, 4-diones as potent and selective inhibitors of the PIM-1, PIM-2, and PIM-3protein kinases", Bioorg Med Chem Lett, 22, pp.4599~4604 (2012)
19. Lee J, "Synthesis and evaluation of 5-(3-(pyra-zin-2-yl)benzylidene)thiazolidine-2, 4-dione derivatives as pan-pim kinases inhibitors", Chem Pharm Bull(Tokyo), 62, pp.906~914 (2014)
20. Nawijn MC, "For better or for worse : the role of Pim oncogenes in tumorigenesis", Nat Rev Cancer, 11, pp.23~34 (2011)
21. Trott O, "AutoDock Vina : improving the speed and accuracy of docking with a new scoring function, efficient optimi-zation, and multithreading", J Comput Chem, 31, pp.455~461 (2010)
22. Sanner MF, "Python : a programming language for software inte-gration and development", J Mol Graph Model, 17, pp.57~61 (1999)

관련 논문AI추천